FindTrial
Sign In

Efficacy of middle ear pressure therapy in patients with intractable Meniere's disease and delayed endolymphatic hydrops

Efficacy of middle ear pressure therapy in patients with intractable Meniere's disease and delayed endolymphatic hydrops - Efficacy of middle ear pressure therapy in patients with intractable Meniere's disease and delayed endolymphatic hydrops

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017710
Enrollment
180
Registered
2015-07-01
Start date
2015-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniere&#39

Interventions

The 3 min-application of positive-negative pressure to the external auditory canal with the middle ear pressure therapy device t.i.d. for 16 weeks.

Sponsors

University of Tokushima
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult (20-80 y/o) patients with intractable definite Meniere's disease and delayed endolymphatic hydrops

Exclusion criteria

Exclusion criteria: 1) Patients with otitis media. 2) Patients with cardiac pacemaker and implantable cardiac defibrillator. 3) Patients with diseases of the auricle and external auditory canal. 4) Patients who was excluded by investigators.

Design outcomes

Primary

MeasureTime frame
Monthly-averaged frequency of vertigo attack—

Secondary

MeasureTime frame
Vestibular and auditory functions—

Countries

Japan

Contacts

Public ContactNoriaki Takeda

University of Tokushima School of Medicine Department of Otolaryngology

takeda@tokushima-u.ac.jp088-633-7169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026